Biomea Fusion Inc
BMEA
NASDAQ
Biotechnology
$1.32
USD
+0.04 (+3.13%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $92.78M
Volume 425.2K
Revenue
$0
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
$-32.54M
TTM
+71.0%
YoY
Operating Cash Flow
$-47.19M
TTM
+52.9%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
YoY Growth | — | — | — | — | — |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative | 4.7 | 4.2 | 3.6 | 3.7 | 3.6 |
Other Operating Expenses | 0.0 | 2.2 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 21.3 | 20.8 | 11.7 | 12.8 | 12.8 |
Operating Income | -21.3 | -20.8 | -11.7 | -12.8 | -12.8 |
EBITDA | -20.8 | -18.2 | -11.7 | -12.7 | -12.7 |
Other Income / Expense | 0.2 | 0.0 | 19.9 | -0.1 | 4.1 |
Total Other Income / Expense | 0.5 | 4.4 | 16.3 | 0.4 | 4.4 |
Income Before Income Taxes | -20.7 | -16.4 | 4.6 | -12.4 | -8.3 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Income | -20.7 | -16.4 | 4.6 | -12.4 | -8.3 |
Consolidated Net Income / Loss | -20.7 | -16.4 | 4.6 | -12.4 | -8.3 |
Net Income Attributable to Common Shareholders | -20.7 | -16.4 | 4.6 | -12.4 | -8.3 |
Basic EPS | -$0.51 | -$0.27 | $0.06 | -$0.17 | -$0.12 |
Diluted EPS | -$0.51 | -$0.27 | $0.06 | -$0.17 | -$0.12 |
Basic Shares Outstanding | 40.6M | 59.8M | 71.8M | 72.3M | 72.4M |
Diluted Shares Outstanding | 40.6M | 59.8M | 71.8M | 72.3M | 72.4M |